Attached files

file filename
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANESOXLEY ACT OF 2002) - ChromaDex Corp.ex32-1.htm
10-Q/A - FORM 10-Q/A - ChromaDex Corp.cdxc10q_apr22016.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 240.13A14 OR 240.15D14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-2.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 240.13A14 OR 240.15D14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-1.htm
EX-10.6 - SECOND AMENDMENT TO NIAGEN SUPPLY AGREEMENT - ChromaDex Corp.ex10-6.htm
EX-10.4 - ADDENDUM TO THE NIAGEN SUPPLY AGREEMENT - ChromaDex Corp.ex10-4.htm
[*] INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION


Exhibit 10.5

FIRST AMENDMENT TO NIAGEN® SUPPLY AGREEMENT
 
THIS AMENDMENT is entered into this 31st day of March 2015 (the “Effective Date” of the First Amendment), by and between 5Linx Enterprises, Inc., with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”) and ChromaDex, Inc., with principals offices located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 (“Seller”).
 
WHEREAS, Buyer and Seller (collectively “the Parties”) entered into a NIAGEN® Supply Agreement made effective as of January 1, 2014 (the “Supply Agreement”); and
 
WHEREAS, the Parties have determined that it is in their mutual interest to amend the Supply Agreement in accordance with the terms of this First Amendment;
 
NOW THEREFORE, in consideration of mutual premises and mutual agreements herein contained, the Parties hereto agree to amend the Supply Agreement as follows:
 
1.           Amend Section 4.1 - 4.3 by replacing them in their entirety with the following:
 
“4.1.      Year 1 (April 1, 2014-March 31, 2015, hereinafter, “Year” begins April 1st): The Buyer will purchase at a minimum of two million one hundred thousand dollars ($2,100,000) of the Product in the first year of the Agreement.  The Buyer will provide an open PO with delivery dates for [*] kilograms ([*]kg) of Product at a price of [*] dollars per kilogram ($[*]/kg).  The first year of the contract will be take or pay for one million five hundred thousand dollars ($1,500,000) and [*] ([*]) kilograms of product will be order within the first nine (9) months of the Effective Date.
 
4.2         Year 2: The Buyer will purchase at a minimum of four million dollars ($4,000,000) of the Product in the second year of the Agreement.  The Buyer will provide quarterly POs with delivery dates for the Product at a price of [*] dollars per kilogram ($[*]/kg).  The quarterly POs will be binding to maintain the exclusivity.
 
4.3         Year 3: The Buyer will purchase at a minimum of seventeen million dollars ($17,000,000) of the Product in the third year of the Agreement.  The Buyer will provide quarterly POs with delivery dates for the Product at a price of [*] dollars per kilogram ($[*]/kg).  The quarterly POs will be binding to maintain the exclusivity.”
 
2.           Except as specifically changed, altered, amended or restructured by this Amendment, all terms and provisions of the Supply Agreement shall remain unchanged and unaffected and in full force and effect.
 
3.           Delivery of an executed counterpart of a signature pate to this First Amendment by email shall be effective as delivered of a manually executed counterpart of this Agreement.

 
 

 
[*] INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION



IN WITHNESS WHEREOF, the Parties hereto have duly executed this First Amendment to the NIAGEN® Supply Agreement as of the date first written above.
 
 
 
CHROMADEX, INC.                                                                     5LINX ENTERPRISES, INC.

 
By: /s/ Troy Rhonemus                                                                  By: /s/ William Faucette Jr.                                                              
 
Name: Troy Rhonemus                                                                   Name: William Faucette Jr.                                                              
Title: COO                                                                                         Title: VP Sales                     
Date: 6/9/2015                                                                                   Date: 5/26/15